UK: NEW ALZHEIMER'S VACCINE TAKES A STEP FORWARD
Article Abstract:
A new vaccine offering protection against Alzheimer's disease has passed a key safety test, it has been revealed. The trial, which was conducted in the US was designed to test the toxicity of the vaccine, and researchers have reported "no obvious safety concerns". It was a year ago that scientists from Elan Pharmaceuticals in California, announced that tests on mice had shown that the vaccine successfully reduced the formation of the protein deposits known as "plaques", which are seen in the brains of people suffering from Alzheimer's. However at the time it was not clear if the vaccine would be safe for humans. Following the latest trial, further safety tests will be conducted on 100 patients in the US and UK, but it will be at least two years before it is clear whether the vaccine can help people with Alzheimer's. Alzheimer's, a degenerative brain disorder, affects around 500,000 people in the UK, and the number of people affected is likely to rise by 50% over the next 40 years as a result of the ageing population. Although drugs have been developed to slow the advancement of the disease, there is still no known cure. Commenting on the news, Harry Cayton, director of the Alzheimer's Disease Society in the UK said the results were interesting, but warned against raising expectations.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
UK: DOCTORS DEMAND MORNING-SICKNESS DRUG
Article Abstract:
An international group of doctors has called for morning sickness to be treated with drugs to prevent the unborn baby's health being affected by vomiting or dehydration in the mother. The drug Diclectin, which prevents nausea and vomiting in pregnancy, has been used to treat 33mn women in the past 25 years in Canada. It has undergone full clinical trials and is about to get approval for use in the United States. British doctors want it approved here as soon as possible. Around two-thirds of women in Britain suffer and some 8.6mn working days are lost because of it.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
UK: NEW STUDY INTO USE OF HRT
Article Abstract:
A new study into the use of hormone replacement therapy (HRT) sponsored by the UK Imperial Cancer Research Fund is to get under way. The study, which is to be the largest of its kind in the world, has benefited from 25% of UK females aged 50 years to 64 years volunteering for the research. The study is aimed at discovering the long-term risks to women of using HRT, which is thought to reduce the risk of heart disease but could result in a slight rise in breast cancer.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: UK: GOVERNMENT'S ECONOMIC POLICIES UNDER FIRE. UK: CASH HANDOUTS FOR UNEMPLOYED. UK: NET ILLITERACY BLAMED FOR JOB CUTS AT PWC
- Abstracts: UK: RISE IN TB CASES CAUSES CONCERN. UK: OLD CJD VICTIM PROMPTS NEW CONCERNS. UK: NEW TEST COULD DETECT EARLY BIRTHS
- Abstracts: UK/IRELAND: BRANSON AIMING TO EXPAND RAIL EMPIRE. UK: RAIL SERVICES IMPROVED BY JANUARY 2001. UK: SRA REVEALS FALL IN TRAIN PUNCTUALITY
- Abstracts: UK: MORGAN STANLEY TO EXPAND IN DOCKLANDS. Dismay over euro fudge. UK: LORD SIMON BECOMES SENIOR ADVISOR TO MORGAN